Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

    Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

    Medical Dialogues Bureau27 March 2020 1:11 PM IST
    Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias, and angina.
    Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

    Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

    Medical Dialogues Bureau27 March 2020 12:51 PM IST
    Cipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is an AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's ...
    Strides Pharma gets USFDA EIR for its Bangalore flagship facility

    Strides Pharma gets USFDA EIR for its Bangalore flagship facility

    Medical Dialogues Bureau27 March 2020 11:26 AM IST
    Bangalore: Strides Pharma has announced that the Company's flagship facility (KRS Gardens) in Bangalore which was inspected by the USFDA in March...
    Glenmark Pharmaceuticals gets tentative ANDA nod for  Dapagliflozin Tablets

    Glenmark Pharmaceuticals gets tentative ANDA nod for Dapagliflozin Tablets

    Medical Dialogues Bureau23 March 2020 8:08 PM IST
    Mumbai: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S....
    USFDA partially lifts import ban on Ipca Labs APIs of Chloroquine Phosphate and Hydroxychloroquine Sulphate

    USFDA partially lifts import ban on Ipca Labs APIs of Chloroquine Phosphate and Hydroxychloroquine Sulphate

    Medical Dialogues Bureau23 March 2020 1:45 PM IST
    Mumbai: IPCA Labs has announced that due to the shortage implications and/or medical necessity of certain drugs and finished products, the United...
    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

    Medical Dialogues Bureau23 March 2020 9:30 AM IST
    It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13...
    Dr Reddys Labs launches Naloxone Hydrochloride Injection in US Market

    Dr Reddy's Labs launches Naloxone Hydrochloride Injection in US Market

    Medical Dialogues Bureau21 March 2020 9:00 AM IST
    Hyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL)...
    Dr Reddys Labs launches Pyrimethamine Tablets in US

    Dr Reddy's Labs launches Pyrimethamine Tablets in US

    Medical Dialogues Bureau20 March 2020 12:14 PM IST
    Dr Reddy’s Pyrimethamine Tablets USP, is available in 25 mg dose in bottle count sizes of 30 and 100.
    Abbott gets USFDA emergency use authorization for COVID-19 molecular test

    Abbott gets USFDA emergency use authorization for COVID-19 molecular test

    Medical Dialogues Bureau20 March 2020 10:15 AM IST
    The Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.
    Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata

    Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata

    Medical Dialogues Bureau19 March 2020 12:56 PM IST
    Baricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
    Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

    Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

    Medical Dialogues Bureau18 March 2020 12:00 PM IST
    Gujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
    Dr Reddys Labs launches Ziprasidone Mesylate for Injection in US Market

    Dr Reddy's Labs launches Ziprasidone Mesylate for Injection in US Market

    Medical Dialogues Bureau18 March 2020 10:00 AM IST
    Hyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok